Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Clinical Pharmacokinetics
Erschienen in: Clinical Pharmacokinetics 6/2012

01.06.2012 | Original Research Article

Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy

A Database for Parameters Required in Physiologically Based Pharmacokinetic Modelling

verfasst von: Dr Khaled Abduljalil, Penny Furness, Trevor N. Johnson, Amin Rostami-Hodjegan, Hora Soltani

Erschienen in: Clinical Pharmacokinetics | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Background: Pregnancy is associated with considerable changes in the physiological, anatomical and biochemical attributes in women. These may alter the exposure to xenobiotics between pregnant and non-pregnant women who receive similar doses, with implications for different susceptibility to environmental pollutants or therapeutic agents. Physiologically based pharmacokinetic (PBPK) models together with in vitro in vivo extrapolation (IVIVE) of absorption, distribution, metabolism and excretion (ADME) characteristics may capture the likely changes. However, such models require comprehensive information on the longitudinal variations of PBPK parameter values; a set of data that are as yet not available from a singular source.
Aim: The aim of this article was to collect, integrate and analyse the available time-variant parameters that are needed for the PBPK modelling of xenobiotic kinetics in a healthy pregnant population.
Methods: A structured literature search was carried out on anatomical, physiological and biochemical parameters likely to change in pregnancy and alter the kinetics of xenobiotics. Collated data were carefully assessed, integrated and analysed for trends with gestational age. Algorithms were generated to describe the changes in parameter values with gestational age. These included changes in maternal weight, the individual organ volumes and blood flows, glomerular filtration rates, and some drug-metabolising enzyme activities.
Results: Articles were identified using relevant keywords, quality appraised and data were extracted by two investigators. Some parameters showed no change with gestational age and for others robust data were not available. However, for many parameters significant changes were reported during the course of pregnancy, e.g. cardiac output, protein binding and expression/activity of metabolizing enzymes. The trend for time-variant parameters was not consistent (with respect to direction and mono-tonicity). Hence, various mathematical algorithms were needed to describe individual parameter values.
Conclusion: Despite the limitations identified in the availability of some values, the collected data presented in this paper provide a potentially useful singular resource for key parameters needed for PBPK modelling in pregnancy. This facilitates the risk assessment of environmental chemicals and therapeutic drug dose adjustments in the pregnant population.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Anger GJ, Piquette-Miller M. Pharmacokinetic studies in pregnant women. Clin Pharmacol Ther 2008 Jan; 83(1): 184–7PubMedCrossRef
2.
Jeong H. Altered drug metabolism during pregnancy: hormonal regulation of drug-metabolizing enzymes. Expert Opin Drug Metab Toxicol 2010 Jun; 6(6): 689–99PubMedCrossRef
3.
Ververs FF, Voorbij HA, Zwarts P, et al. Effect of cytochrome P450 2D6 genotype on maternal paroxetine plasma concentrations during pregnancy. Clin Pharmacokinet 2009; 48(10): 677–83PubMedCrossRef
4.
Hodge LS, Tracy TS. Alterations in drug disposition during pregnancy: implications for drug therapy. Expert Opin Drug Metab Toxicol 2007 Aug; 3(4): 557–71PubMedCrossRef
5.
Clapp JF, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997 Dec 1; 80(11): 1469–73PubMedCrossRef
6.
De Swiet M. The cardiovascular system. In: Hytten F, Chamberlain G, editors. Clinical physiology in obstetrics. 2nd ed. Oxford: Blackwell Science Ltd, 1991: 3–38
7.
Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965 Jul–Aug; 26: 393–9PubMedCrossRef
8.
Chapman AB, Abraham WT, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998 Dec; 54(6): 2056–63PubMedCrossRef
9.
Brown MA, Whitworth JA. The kidney in hypertensive pregnancies: victim and villain. Am J Kidney Dis 1992 Nov; 20(5): 427–42PubMed
10.
Lindheimer MD, Katz AI. Sodium and diuretics in pregnancy. N Engl J Med 1973 Apr 26; 288(17): 891–4PubMedCrossRef
11.
Headley J, Northstone K, Simmons H, et al. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol 2004 Jul; 60(5): 355–61PubMedCrossRef
12.
Andrade SE, Gurwitz JH, Davis RL, et al. Prescription drug use in pregnancy. Am J Obstet Gynecol 2004 Aug; 191(2): 398–407PubMedCrossRef
13.
Cohen LS, Altshuler LL, Harlow BL, et al. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 2006 Feb 1; 295(5): 499–507PubMedCrossRef
14.
Ramos E, St-Andre M, Rey E, et al. Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 2008 May; 192(5): 344–50PubMedCrossRef
15.
Andrade SE, Raebel MA, Brown J, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008 Feb; 198(2): 194e1–5CrossRef
16.
Davis RL, Rubanowice D, McPhillips H, et al. Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007 Oct; 16(10): 1086–94PubMedCrossRef
17.
Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005; 44(10): 989–1008PubMedCrossRef
18.
Little BB. Pharmacokinetics during pregnancy: evidence-based maternal dose formulation. Obstet Gynecol 1999 May; 93(5 Pt 2): 858–68PubMedCrossRef
19.
20.
Johnson TN, Rostami-Hodjegan A. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr Anaesth 2011 Mar; 21(3): 291–301PubMedCrossRef
21.
Beaudouin R, Micallef S, Brochot C. A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan. Regul Toxicol Pharmacol 2010 Jun; 57(1): 103–16PubMedCrossRef
22.
Jamei M, Dickinson GL, Rostami-Hodjegan A. A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: a tale of ‘bottom-up’ vs ‘top-down’ recognition of covariates. Drug Metab Pharmacokinet 2009; 24(1): 53–75PubMedCrossRef
23.
Andrew MA, Hebert MF, Vicini P. Physiologically based pharmacokinetic model of midazolam disposition during pregnancy. Conf Proc IEEE Eng Med Biol Soc 2008; 2008: 5454–7PubMed
24.
Corley RA, Mast TJ, Carney EW, et al. Evaluation of physiologically based models of pregnancy and lactation for their application in children’s health risk assessments. Crit Rev Toxicol 2003; 33(2): 137–211PubMedCrossRef
25.
Young JF, Branham WS, Sheehan DM, et al. Physiological “constants” for PBPK models for pregnancy. J Toxicol Environ Health 1997 Dec 12; 52(5): 385–401PubMed
26.
Luecke RH, Wosilait WD, Pearce BA, et al. A physiologically based pharmacokinetic computer model for human pregnancy. Teratology 1994 Feb; 49(2): 90–103PubMedCrossRef
27.
Luecke RH, Wosilait WD, Pearce BA, et al. A computer model and program for xenobiotic disposition during pregnancy. Comput Methods Programs Biomed 1997 Jul; 53(3): 201–24PubMedCrossRef
28.
Gentry PR, Covington TR, Andersen ME, et al. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 2002 Aug; 36(1): 51–68PubMedCrossRef
29.
Gentry PR, Covington TR, Clewell 3rd HJ. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul Toxicol Pharmacol 2003 Aug; 38(1): 1–16PubMedCrossRef
30.
Aitchison J, Brown JAC. The log normal distribution. Cambridge: University Press, 1966
31.
Armitage P, Berry J, Matthews JNS. Statistical methods in medical research. 4th ed. Oxford: Blackwell Science, 2002CrossRef
32.
Haddad S, Restieri C, Krishnan K. Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans. J Toxicol Environ Health 2001 Nov 23; 64(6): 453–64CrossRef
33.
Young JF, Luecke RH, Pearce BA, et al. Human organ/tissue growth algorithms that include obese individuals and black/white population organ weight similarities from autopsy data. J Toxicol Environ Health 2009; 72(8): 527–40CrossRef
34.
Thomas D, Das SK, Levine JA, et al. New fat free mass: fat mass model for use in physiological energy balance equations. Nutr Metab (Lond) 2010; 7: 39CrossRef
35.
Butte NF, Ellis KJ, Wong WW, et al. Composition of gestational weight gain impacts maternal fat retention and infant birth weight. Am J Obstet Gynecol 2003 Nov; 189(5): 1423–32PubMedCrossRef
36.
Kopp-Hoolihan LE, van Loan MD, Wong WW, et al. Longitudinal assessment of energy balance in well-nourished, pregnant women. Am J Clin Nutr 1999 Apr; 69(4): 697–704PubMed
37.
Lof M, Olausson H, Bostrom K, et al. Changes in basal metabolic rate during pregnancy in relation to changes in body weight and composition, cardiac output, insulin-like growth factor I, and thyroid hormones and in relation to fetal growth. Am J Clin Nutr 2005 Mar; 81(3): 678–85PubMed
38.
Hebert MF, Easterling TR, Kirby B, et al. Effects of pregnancy on CYP3A and P-glycoprotein activities as measured by disposition of midazolam and digoxin: a University of Washington specialized center of research study. Clin Pharmacol Ther 2008 Aug; 84(2): 248–53PubMedCrossRef
39.
Lof M, Hilakivi-Clarke L, Sandin SS, et al. Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Womens Health 2009; 9: 10PubMedCrossRef
40.
Abrams B, Selvin S. Maternal weight gain pattern and birth weight. Obstet Gynecol 1995 Aug; 86(2): 163–9PubMedCrossRef
41.
Catalano PM, Roman-Drago NM, Amini SB, et al. Longitudinal changes in body composition and energy balance in lean women with normal and abnormal glucose tolerance during pregnancy. Am J Obstet Gynecol 1998 Jul; 179(1): 156–65PubMedCrossRef
42.
de Groot LC, Boekholt HA, Spaaij CK, et al. Energy balances of healthy Dutch women before and during pregnancy: limited scope for metabolic adaptations in pregnancy. Am J Clin Nutr 1994 Apr; 59(4): 827–32PubMed
43.
Edouard DA, Pannier BM, London GM, et al. Venous and arterial behavior during normal pregnancy. Am J Physiol 1998 May; 274(5 Pt 2): H1605–12PubMed
44.
Ghezzi F, Franchi M, Balestreri D, et al. Bioelectrical impedance analysis during pregnancy and neonatal birth weight. Eur J Obstet Gynecol Re-product Biol 2001 Oct; 98(2): 171–6CrossRef
45.
Larciprete G, Valensise H, Vasapollo B, et al. Body composition during normal pregnancy: reference ranges. Acta Diabetol 2003 Oct; 40 Suppl. 1: S225–32PubMedCrossRef
46.
Wolfe WS, Sobal J, Olson CM, et al. Parity-associated weight gain and its modification by sociodemographic and behavioral factors: a prospective analysis in US women. Int J Obes Relat Metab Disord 1997 Sep; 21(9): 802–10PubMedCrossRef
47.
Hronek M, Klemera P, Tosner J, et al. Anthropometric measured fat-free mass as essential determinant of resting energy expenditure for pregnant and non-pregnant women. Nutrition 2011 Sep; 27(9): 885–90PubMedCrossRef
48.
Kopp-Hoolihan LE, van Loan MD, Wong WW, et al. Fat mass deposition during pregnancy using a four-component model. J Appl Physiol 1999 Jul; 87(1): 196–202PubMed
49.
Goldberg GR, Prentice AM, Coward WA, et al. Longitudinal assessment of the components of energy balance in well-nourished lactating women. Am J Clin Nutr 1991 Nov; 54(5): 788–98PubMed
50.
Lederman SA, Paxton A, Heymsfield SB, et al. Body fat and water changes during pregnancy in women with different body weight and weight gain. Obstet Gynecol 1997 Oct; 90(4 Pt 1): 483–8PubMedCrossRef
51.
Van Loan MD, Kopp LE, King JC, et al. Fluid changes during pregnancy: use of bioimpedance spectroscopy. J Appl Physiol 1995 Mar; 78(3): 1037–42PubMed
52.
Lof M, Forsum E. Evaluation of bioimpedance spectroscopy for measurements of body water distribution in healthy women before, during, and after pregnancy. J Appl Physiol 2004 Mar; 96(3): 967–73PubMedCrossRef
53.
Deurenberg P. Body composition techniques in health and disease. Cambridge: Cambridge University Press, 1995: 45–56CrossRef
54.
Frederiksen MC, Ruo TI, Chow MJ, et al. Theophylline pharmacokinetics in pregnancy. Clin Pharmacol Ther 1986 Sep; 40(3): 321–8PubMedCrossRef
55.
Lukaski HC, Siders WA, Nielsen EJ, et al. Total body water in pregnancy: assessment by using bioelectrical impedance. Am J Clin Nutr 1994 Mar; 59(3): 578–85PubMed
56.
Pipe NG, Smith T, Halliday D, et al. Changes in fat, fat-free mass and body water in human normal pregnancy. Br J Obstet Gynaecol 1979 Dec; 86(12): 929–40PubMedCrossRef
57.
Seitchik J. Total body water and total body density of pregnant women. Obstet Gynecol 1967 Feb; 29(2): 155–66PubMed
58.
Valensise H, Andreoli A, Lello S, et al. Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy. Am J Clin Nutr 2000 Sep; 72(3): 780–3PubMed
59.
Forsum E, Sadurskis A, Wager J. Resting metabolic rate and body composition of healthy Swedish women during pregnancy. Am J Clin Nutr 1988 Jun; 47(6): 942–7PubMed
60.
van Marken Lichtenbelt WD, Snel YE, Brummer RJ, et al. Deuterium and bromide dilution, and bioimpedance spectrometry independently show that growth hormone-deficient adults have an enlarged extracellular water compartment related to intracellular water. J Clin Endocrinol Metab 1997 Mar; 82(3): 907–11PubMedCrossRef
61.
Clark SL, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989 Dec; 161(6 Pt 1): 1439–42PubMedCrossRef
62.
Robson SC, Hunter S, Boys RJ, et al. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol 1989 Apr; 256(4 Pt 2): 1060–5
63.
Easterling TR, Benedetti TJ, Schmucker BC, et al. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990 Dec; 76(6): 1061–9PubMed
64.
Del Bene R, Barletta G, Mello G, et al. Cardiovascular function in pregnancy: effects of posture. BJOG 2001 Apr; 108(4): 344–52PubMedCrossRef
65.
Hale SA, Schonberg A, Badger GJ, et al. Relationship between prepregnancy and early pregnancy uterine blood flow and resistance index. Reprod Sci 2009 Nov; 16(11): 1091–6PubMedCrossRef
66.
Hennessy TG, MacDonald D, Hennessy MS, et al. Serial changes in cardiac output during normal pregnancy: a Doppler ultrasound study. Eur J Obstet Gynecol Reproduct Biol 1996 Dec 27; 70(2): 117–22CrossRef
67.
Mesa A, Jessurun C, Hernandez A, et al. Left ventricular diastolic function in normal human pregnancy. Circulation 1999 Feb 2; 99(4): 511–7PubMedCrossRef
68.
Salas SP, Marshall G, Gutierrez BL, et al. Time course of maternal plasma volume and hormonal changes in women with preeclampsia or fetal growth restriction. Hypertension 2006 Feb; 47(2): 203–8PubMedCrossRef
69.
Bernstein IM, Ziegler W, Badger GJ. Plasma volume expansion in early pregnancy. Obstet Gynecol 2001 May; 97(5 Pt 1): 669–72PubMedCrossRef
70.
Lund CJ, Donovan JC. Blood volume during pregnancy. Significance of plasma and red cell volumes. Am J Obstet Gynecol 1967 Jun 1; 98(3): 394–403PubMed
71.
Whittaker PG, Lind T. The intravascular mass of albumin during human pregnancy: a serial study in normal and diabetic women. Br J Obstet Gynaecol 1993 Jun; 100(6): 587–92PubMedCrossRef
72.
Campbell DM, MacGillivray I. Comparison of maternal response in first and second pregnancies in relation to baby weight. J Obstet Gynaecol Br Commonw 1972 Aug; 79(8): 684–93PubMedCrossRef
73.
Rovinsky JJ, Jaffin H. Cardiovascular hemodynamics in pregnancy. I. Blood and plasma volumes in multiple pregnancy. Am J Obstet Gynecol 1965 Sep 1; 93: 1–15PubMed
74.
Caton WL, Roby CC, Reid DE, et al. The circulating red cell volume and body hematocrit in normal pregnancy and the puerperium by direct measurement using radioactive red cells. Am J Obstet Gynecol 1951 Jun; 61(6): 1207–17PubMed
75.
Honger PE. Intravascular mass of albumin in pre-eclampsia and normal pregnancy. Scand J Clin Lab Invest 1967; 19(3): 283–7PubMedCrossRef
76.
Verel D, Bury JD, Hope A. Blood volume changes in pregnancy and the puerperium. Clin Sci (Lond) 1956 Feb; 15(1): 1–7
77.
Whittaker PG, Macphail S, Lind T. Serial hematologic changes and pregnancy outcome. Obstet Gynecol 1996 Jul; 88(1): 33–9PubMedCrossRef
78.
Bruinse HW, van den Berg H, Haspels AA. Smoking and its effect on maternal plasma volume during and after normal pregnancy. Eur J Obstet Gynecol Reproduct Biol 1985 Oct; 20(4): 215–9CrossRef
79.
Cope I. Plasma and blood volume changes in late and prolonged pregnancy. J Obstet Gynaecol Br Empire 1958 Dec; 65(6): 877–94CrossRef
80.
Hytten FE, Paintin DB. Increase in plasma volume during normal pregnancy. J Obstet Gynaecol Br Emp 1963 Jun; 70: 402–7PubMedCrossRef
81.
Pirani BB, Campbell DM, MacGillivray I. Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw 1973 Oct; 80(10): 884–7PubMedCrossRef
82.
Silver HM, Seebeck M, Carlson R. Comparison of total blood volume in normal, preeclamptic, and nonproteinuric gestational hypertensive pregnancy by simultaneous measurement of red blood cell and plasma volumes. Am J Obstet Gynecol 1998 Jul; 179(1): 87–93PubMedCrossRef
83.
Robson SC, Mutch E, Boys RJ, et al. Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance. Br J Obstet Gynaecol 1990 Aug; 97(8): 720–4PubMedCrossRef
84.
Darby WJ, Mc GW, Martin MP, et al. The Vanderbilt cooperative study of maternal and infant nutrition. IV: dietary, laboratory and physical findings in 2,129 delivered pregnancies. J Nutr 1953 Dec 10; 51(4): 565–97PubMed
85.
Lundstrom P. Studies on erythroid elements and serum iron in normal pregnancy. Acta Soc Med Ups 1950 Jan; 55(1/2): 1–83PubMed
86.
Pond SM, Kreek MJ, Tong TG, et al. Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther 1985 Apr; 233(1): 1–6PubMed
87.
Sala C, Campise M, Ambroso G, et al. Atrial natriuretic peptide and hemodynamic changes during normal human pregnancy. Hypertension 1995 Apr; 25(4 Pt 1): 631–6PubMedCrossRef
88.
Duvekot JJ, Cheriex EC, Pieters FA, et al. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 1993 Dec; 169(6): 1382–92PubMedCrossRef
89.
Haram K, Augensen K, Elsayed S. Serum protein pattern in normal pregnancy with special reference to acute-phase reactants. Br J Obstet Gynaecol 1983 Feb; 90(2): 139–45PubMedCrossRef
90.
Connelly TJ, Ruo TI, Frederiksen MC, et al. Characterization of theophylline binding to serum proteins in pregnant and nonpregnant women. Clin Pharmacol Ther 1990 Jan; 47(1): 68–72PubMedCrossRef
91.
Mendenhall HW. Serum protein concentrations in pregnancy. I: concentrations in maternal serum. Am J Obstet Gynecol 1970 Feb 1; 106(3): 388–99PubMed
92.
Tsen LC, Tarshis J, Denson DD, et al. Measurements of maternal protein binding of bupivacaine throughout pregnancy. Anesth Analg 1999 Oct; 89(4): 965–8PubMed
93.
Chu CY, Singla VP, Wang HP, et al. Plasma alpha 1-acid glycoprotein levels in pregnancy. Clinica Chimica Acta 1981 May 5; 112(2): 235–40CrossRef
94.
Krauer B, Dayer P, Anner R. Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol 1984 Sep; 91(9): 875–81PubMedCrossRef
95.
Tsen LC, Arthur GR, Datta S, et al. Estrogen-induced changes in protein binding of bupivacaine during in vitro fertilization. Anesthesiology 1997 Oct; 87(4): 879–83PubMedCrossRef
96.
Wang HP, Chu CY. A solid-phase enzyme-linked immunosorbent assay for the quantitation of human plasma alpha 1-acid glycoprotein. Clin Chem 1979 Apr; 25(4): 546–9PubMed
97.
Reboud P, Groulade J, Groslambert P, et al. The influence of normal pregnancy and the postpartum state on plasma proteins and lipids. Am J Obstet Gynecol 1963 Jul 15; 86: 820–8PubMed
98.
Desoye G, Schweditsch MO, Pfeiffer KP, et al. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 1987 Apr; 64(4): 704–12PubMedCrossRef
99.
Alvarez JJ, Montelongo A, Iglesias A, et al. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 1996 Feb; 37(2): 299–308PubMed
100.
Butler CL, Williams MA, Sorensen TK, et al. Relation between maternal recreational physical activity and plasma lipids in early pregnancy. Am J Epidemiol 2004 Aug 15; 160(4): 350–9PubMedCrossRef
101.
Lippi G, Albiero A, Montagnana M, et al. Lipid and lipoprotein profile in physiological pregnancy. Clin Lab 2007; 53(3–4): 173–7PubMed
102.
Tracy TS, Venkataramanan R, Glover DD, et al. Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy. Am J Obstet Gynecol 2005 Feb; 192(2): 633–9PubMedCrossRef
103.
Dunlop W. Serial changes in renal haemodynamics during normal human pregnancy. Br J Obstet Gynaecol 1981 Jan; 88(1): 1–9PubMedCrossRef
104.
Assali NS, Dignam WJ, Dasgupta K. Renal function in human pregnancy: II. Effects of venous pooling on renal hemodynamics and water, electrolyte, and aldosterone excretion during gestation. J Lab Clin Med 1959 Sep; 54: 394–408PubMed
105.
Davison JM, Hytten FE. Glomerular filtration during and after pregnancy. J Obstet Gynaecol Br Commonw 1974 Aug; 81(8): 588–95PubMedCrossRef
106.
Irons DW, Baylis PH, Davison JM. Effect of atrial natriuretic peptide on renal hemodynamics and sodium excretion during human pregnancy. Am J Physiol 1996 Jul; 271(1 Pt 2): F239–42PubMed
107.
Lafayette RA, Druzin M, Sibley R, et al. Nature of glomerular dysfunction in pre-eclampsia. Kidney Int 1998 Oct; 54(4): 1240–9PubMedCrossRef
108.
Moran P, Baylis PH, Lindheimer MD, et al. Glomerular ultrafiltration in normal and preeclamptic pregnancy. J Am Soc Nephrol 2003 Mar; 14(3): 648–52PubMedCrossRef
109.
Sims EA, Krantz KE. Serial studies of renal function during pregnancy and the puerperium in normal women. J Clin Invest 1958 Dec; 37(12): 1764–74PubMedCrossRef
110.
Spaanderman M, Ekhart T, van Eyck J, et al. Preeclampsia and maladaptation to pregnancy: a role for atrial natriuretic peptide? Kidney Int 2001 Oct; 60(4): 1397–406PubMedCrossRef
111.
Sturgiss SN, Wilkinson R, Davison JM. Renal reserve during human pregnancy. Am J Physiol 1996 Jul; 271(1 Pt 2): F16–20PubMed
112.
Andrew MA, Easterling TR, Carr DB, et al. Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. Clin Pharmacol Ther 2007 Apr; 81(4): 547–56PubMedCrossRef
113.
Davison JM, Dunlop W, Ezimokhai M. 24-Hour creatinine clearance during the third trimester of normal pregnancy. Br J Obstet Gynaecol 1980 Feb; 87(2): 106–9PubMedCrossRef
114.
Davison JM, Noble MC. Serial changes in 24 hour creatinine clearance during normal menstrual cycles and the first trimester of pregnancy. Br J Obstet Gynaecol 1981 Jan; 88(1): 10–7PubMedCrossRef
115.
Vural P, Akgul C, Canbaz M. Urinary PGE2 and PGF2alpha levels and renal functions in preeclampsia. Gynecol Obstet Invest 1998; 45(4): 237–41PubMedCrossRef
116.
De Alvarez RR. Renal glomerulotubular mechanisms during normal pregnancy. I: glomerular filtration rate, renal plasma flow, and creatinine clearance. Am J Obstet Gynecol 1958 May; 75(5): 931–44
117.
Nevo O, Soustiel JF, Thaler I. Maternal cerebral blood flow during normal pregnancy: a cross-sectional study. Am J Obstet Gynecol 2010 Nov; 203(5): 475e1–6CrossRef
118.
Hytten FE, Cheyne GA. The size and composition of the human pregnant uterus. J Obstet Gynaecol Br Commonw 1969 May; 76(5): 400–3PubMedCrossRef
119.
Woessner JF, Brewer TH. Formation and breakdown of collagen and elastin in the human uterus during pregnancy and post-partum involution. Biochemical J 1963 Oct; 89: 75–82
120.
Morrione TG, Seifter S. Alteration in the collagen content of the human uterus during pregnancy and post partum involution. J Exp Med 1962 Feb 1; 115: 357–65PubMedCrossRef
121.
Flo K, Wilsgaard T, Vartun A, et al. A longitudinal study of the relationship between maternal cardiac output measured by impedance cardiography and uterine artery blood flow in the second half of pregnancy. BJOG 2010 Jun; 117(7): 837–44PubMedCrossRef
122.
Thaler I, Manor D, Itskovitz J, et al. Changes in uterine blood flow during human pregnancy. Am J Obstet Gynecol 1990 Jan; 162(1): 121–5PubMedCrossRef
123.
Bernstein IM, Ziegler WF, Leavitt T, et al. Uterine artery hemodynamic adaptations through the menstrual cycle into early pregnancy. Obstet Gynecol 2002 Apr; 99(4): 620–4PubMedCrossRef
124.
Dickey RP, Hower JF. Ultrasonographic features of uterine blood flow during the first 16 weeks of pregnancy. Human Reprod 1995 Sep; 10(9): 2448–52
125.
Jeffreys RM, Stepanchak W, Lopez B, et al. Uterine blood flow during supine rest and exercise after 28 weeks of gestation. BJOG 2006 Nov; 113(11): 1239–47PubMedCrossRef
126.
Konje JC, Howarth ES, Kaufmann P, et al. Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction. BJOG 2003 Mar; 110(3): 301–5PubMedCrossRef
127.
Konje JC, Kaufmann P, Bell SC, et al. A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am J Obstet Gynecol 2001 Sep; 185(3): 608–13PubMedCrossRef
128.
Metcalfe J, Romney SL, Ramsey LH, et al. Estimation of uterine blood flow in normal human pregnancy at term. J Clin Invest 1955 Nov; 34(11): 1632–8PubMedCrossRef
129.
Palmer SK, Zamudio S, Coffin C, et al. Quantitative estimation of human uterine artery blood flow and pelvic blood flow redistribution in pregnancy. Obstet Gynecol 1992 Dec; 80(6): 1000–6PubMed
130.
Rigano S, Ferrazzi E, Boito S, et al. Blood flow volume of uterine arteries in human pregnancies determined using 3D and bi-dimensional imaging, angio-Doppler, and fluid-dynamic modeling. Placenta 2010 Jan; 31(1): 37–43PubMedCrossRef
131.
Wilson MJ, Lopez M, Vargas M, et al. Greater uterine artery blood flow during pregnancy in multigenerational (Andean) than shorter-term (European) high-altitude residents. Am J Physiol 2007 Sep; 293(3): R1313–24
132.
Cox DB, Kent JC, Casey TM, et al. Breast growth and the urinary excretion of lactose during human pregnancy and early lactation: endocrine relationships. Exp Physiol 1999 Mar; 84(2): 421–34PubMedCrossRef
133.
Hytten FE. Clinical and chemical studies in human lactation. VI: the functional capacity of the breast. Br Med J 1954 Apr 17; 1(4867): 912–5PubMedCrossRef
134.
Eder M, Schneider A, Feussner H, et al. Breast volume assessment based on 3D surface geometry: verification of the method using MR imaging [in German]. Biomed Tech (Berl) 2008 Jun; 53(3): 112–21CrossRef
135.
Kovacs L, Eder M, Hollweck R, et al. New aspects of breast volume measurement using 3-dimensional surface imaging. Ann Plast Surg 2006 Dec; 57(6): 602–10PubMedCrossRef
136.
Thoresen M, Wesche J. Doppler measurements of changes in human mammary and uterine blood flow during pregnancy and lactation. Acta Obstet Gynecol Scand 1988; 67(8): 741–5PubMedCrossRef
137.
Hussain Z, Roberts N, Whitehouse GH, et al. Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. Br J Radiol 1999 Mar; 72(855): 236–45PubMed
138.
Kovacs L, Eder M, Hollweck R, et al. Comparison between breast volume measurement using 3D surface imaging and classical techniques. Breast 2007 Apr; 16(2): 137–45PubMedCrossRef
139.
Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, et al. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev 2006 Nov; 15(11): 2123–30PubMedCrossRef
140.
Dickey RP, Hower JF. Relationship of estradiol and progesterone levels to uterine blood flow during early pregnancy. Early Pregnancy 1996 Jun; 2(2): 113–20PubMed
141.
Potischman N, Troisi R, Thadhani R, et al. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev 2005 Jun; 14(6): 1514–20PubMedCrossRef
142.
Risberg A, Olsson K, Lyrenas S, et al. Plasma vasopressin, oxytocin, estradiol, and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand 2009; 88(6): 639–46PubMedCrossRef
143.
Tamimi R, Lagiou P, Vatten LJ, et al. Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev 2003 Jul; 12(7): 647–50PubMed
144.
Tulchinsky D, Korenman SG. The plasma estradiol as an index of fetoplacental function. J Clin Invest 1971 Jul; 50(7): 1490–7PubMedCrossRef
145.
Wald A, Van Thiel DH, Hoechstetter L, et al. Effect of pregnancy on gastrointestinal transit. Dig Dis Sci 1982 Nov; 27(11): 1015–8PubMedCrossRef
146.
Fu Q, VanGundy TB, Shibata S, et al. Menstrual cycle affects renal-adrenal and hemodynamic responses during prolonged standing in the postural orthostatic tachycardia syndrome. Hypertension 2010 Jul; 56(1): 82–90PubMedCrossRef
147.
Kern Jr F, Everson GT, DeMark B, et al. Biliary lipids, bile acids, and gallbladder function in the human female: effects of pregnancy and the ovulatory cycle. J Clin Invest 1981 Nov; 68(5): 1229–42PubMedCrossRef
148.
Winkel P, Gaede P, Lyngbye J. Method for monitoring plasma progesterone concentrations in pregnancy. Clin Chem 1976 Apr; 22(4): 422–8PubMed
149.
Jones TB, Price RR, Gibbs SJ. Volumetric determination of placental and uterine growth relationships from B-mode ultrasound by serial area-volume determinations. Invest Radiol 1981 Mar–Apr; 16(2): 101–6PubMedCrossRef
150.
Geirsson RT, Ogston SA, Patel NB, et al. Growth of total intrauterine, intra-amniotic and placental volume in normal singleton pregnancy measured by ultrasound. Br J Obstet Gynaecol 1985 Jan; 92(1): 46–53PubMedCrossRef
151.
Falcon O, Wegrzyn P, Faro C, et al. Gestational sac volume measured by three-dimensional ultrasound at 11 to 13+6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2005 Jun; 25(6): 546–50PubMedCrossRef
152.
Lee W, Deter RL, McNie B, et al. Quantitative and morphological assessment of early gestational sacs using three-dimensional ultrasonography. Ultrasound Obstet Gynecol 2006 Sep; 28(3): 255–60PubMedCrossRef
153.
Muller T, Sutterlin M, Pohls U, et al. Transvaginal volumetry of first trimester gestational sac: a comparison of conventional with three-dimensional ultrasound. J Perinat Med 2000; 28(3): 214–20PubMedCrossRef
154.
Steiner H, Gregg AR, Bogner G, et al. First trimester three-dimensional ultrasound volumetry of the gestational sac. Arch Gynecol Obstet 1994; 255(4): 165–70PubMedCrossRef
155.
Jirasek JE, Uher J, Uhrova M. Water and nitrogen content of the body of young human embryos. Am J Obstet Gynecol 1966 Nov 15; 96(6): 868–71PubMed
156.
Thomson AM, Billewicz WZ, Hytten FE. The weight of the placenta in relation to birthweight. J Obstet Gynaecol Br Commonw 1969 Oct; 76(10): 865–72PubMedCrossRef
157.
Bonellie S, Chalmers J, Gray R, et al. Centile charts for birthweight for gestational age for Scottish singleton births. BMC Pregnancy Childbirth 2008; 8: 5PubMedCrossRef
158.
Abramovich DR. The volume of amniotic fluid in early pregnancy. J Obstet Gynaecol Br Commonw 1968 Jul; 75(7): 728–31PubMedCrossRef
159.
Lind T, Kendall A, Hytten FE. The role of the fetus in the formation of amniotic fluid. J Obstet Gynaecol Br Commonw 1972 Apr; 79(4): 289–98PubMedCrossRef
160.
Smith DL. Amniotic fluid volume. A measurement of the amniotic fluid present in 72 pregnancies during the first half of pregnancy. Am J Obstet Gynecol 1971 May 15; 110(2): 166–72PubMed
161.
Clapp JF, Rizk KH, Appleby-Wineberg SK, et al. Second-trimester placental volumes predict birth weight at term. J Soc Gynecol Invest 1995 Jan–Feb; 2(1): 19–22CrossRef
162.
Hafner E, Schuchter K, van Leeuwen M, et al. Three-dimensional sonographic volumetry of the placenta and the fetus between weeks 15 and 17 of gestation. Ultrasound Obstet Gynecol 2001 Aug; 18(2): 116–20PubMedCrossRef
163.
Hertig AT, Rock J, Adams EC. A description of 34 human ova within the first 17 days of development. Am J Anat 1956 May; 98(3): 435–93PubMedCrossRef
164.
Jackson CM. On the prenatal growth of the human body and the relative growth of the various organs and parts. Am J Anat 1909; 9(1): 119–65CrossRef
165.
McKeown T, Record RG. The influence of placental size on foetal growth according to sex and order of birth. J Endocrinol 1953 Nov; 10(1): 73–81PubMedCrossRef
166.
Molteni RA, Stys SJ, Battaglia FC. Relationship of fetal and placental weight in human beings: fetal/placental weight ratios at various gestational ages and birth weight distributions. J Reproduct Med 1978 Nov; 21(5): 327–34
167.
Osei EK, Faulkner K. Fetal position and size data for dose estimation. Br J Radiol 1999 Apr; 72(856): 363–70PubMed
168.
Verburg BO, Jaddoe VW, Wladimiroff JW, et al. Fetal hemodynamic adaptive changes related to intrauterine growth: the Generation R Study. Circulation 2008 Feb 5; 117(5): 649–59PubMedCrossRef
169.
Mayhew TM, Sorensen FB, Klebe JG, et al. The effects of mode of delivery and sex of newborn on placental morphology in control and diabetic pregnancies. J Anat 1993 Dec; 183(Pt 3): 545–52PubMed
170.
Wilcox M, Gardosi J, Mongelli M, et al. Birth weight from pregnancies dated by ultrasonography in a multicultural British population. BMJ 1993 Sep 4; 307(6904): 588–91PubMedCrossRef
171.
Wolf H, Oosting H, Treffers PE. Placental volume measurement by ultrasonography: evaluation of the method. Am J Obstet Gynecol 1987 May; 156(5): 1191–4PubMed
172.
Hellman LM, Kobayashi M, Tolles WE, et al. Ultrasonic studies on the volumetric growth of the human placenta. Am J Obstet Gynecol 1970 Nov 1; 108(5): 740–50PubMed
173.
Bozkurt N, Basgul Yigiter A, Gokaslan H, et al. Correlations of fetal-maternal outcomes and first trimester 3-D placental volume/3-D power Doppler calculations. Clin Exp Obstet Gynecol 2010; 37(1): 26–8PubMed
174.
Bujold E, Effendi M, Girard M, et al. Reproducibility of first trimester three-dimensional placental measurements in the evaluation of early placental insufficiency. J Obstet Gynaecol Can 2009 Dec; 31(12): 1144–8PubMed
175.
Howe D, Wheeler T, Perring S. Measurement of placental volume with real-time ultrasound in mid-pregnancy. J Clin Ultrasound 1994 Feb; 22(2): 77–83PubMedCrossRef
176.
Pardi G, Cetin I. Human fetal growth and organ development: 50 years of discoveries. Am J Obstet Gynecol 2006 Apr; 194(4): 1088–99PubMedCrossRef
177.
Perry IJ, Beevers DG, Whincup PH, et al. Predictors of ratio of placental weight to fetal weight in multiethnic community. BMJ 1995 Feb 18; 310(6977): 436–9PubMedCrossRef
178.
Wegrzyn P, Faro C, Falcon O, et al. Placental volume measured by three-dimensional ultrasound at 11 to 13+6 weeks of gestation: relation to chromosomal defects. Ultrasound Obstet Gynecol 2005 Jul; 26(1): 28–32PubMedCrossRef
179.
Wolf H, Oosting H, Treffers PE. Second-trimester placental volume measurement by ultrasound: prediction of fetal outcome. Am J Obstet Gynecol 1989 Jan; 160(1): 121–6PubMedCrossRef
180.
Rhodes P. The volume of liquor amnii in early pregnancy. J Obstet Gynaecol Br Commonw 1966 Feb; 73(1): 23–6PubMedCrossRef
181.
Fuchs F. Volume of amniotic fluid at various stages of pregnancy. Clin Obstet Gynecol 1966 Jun; 9(2): 449–60PubMedCrossRef
182.
Charles D, Jacoby HE, Burgess F. Amniotic fluid volumes in the second half of pregnancy. Am J Obstet Gynecol 1965 Dec 1; 93(7): 1042–7PubMed
183.
Elliott PM, Inman WH. Volume of liquor amnii in normal and abnormal pregnancy. Lancet 1961 Oct 14; 2(7207): 835–40PubMedCrossRef
184.
Gadd RL. The volume of the liquor amnii. Proc. Royal Soc Med 1966 Nov; 59(11 Part 1): 1131–3
185.
Gillibrand PN. Changes in amniotic fluid volume with advancing pregnancy. J Obstet Gynaecol Br Commonw 1969 Jun; 76(6): 527–9PubMedCrossRef
186.
Lind T, Hytten FE. Relation of amniotic fluid volume to fetal weight in the first half of pregnancy. Lancet 1970 May 30; 1(7657): 1147–9PubMedCrossRef
187.
188.
Macfarlane A, Mugford M. Birth counts: statistics of pregnancy and childbirth. 2nd ed. London: The Stationery Office, 2000
189.
Chow YH, Dattani N. Estimating conception statistics using gestational age information from NHS Numbers for Babies data. Health Stat Q 2009 Spring; (41): 21–7PubMedCrossRef
190.
Papageorghiou AT, Bakoulas V, Sebire NJ, et al. Intrauterine growth in multiple pregnancies in relation to fetal number, chorionicity and gestational age. Ultrasound Obstet Gynecol 2008 Dec; 32(7): 890–3PubMedCrossRef
191.
Bergsjo P, Denman DW, Hoffman HJ, et al. Duration of human singleton pregnancy: a population-based study. Acta Obstet Gynecol Scand 1990; 69(3): 197–207PubMedCrossRef
192.
193.
Rasmussen K, Yaktine A, editors. Weight gain during pregnancy: reexamining the guidelines. Washington, DC: National Academies Press, 2009
194.
Billewicz WC, Thomson AM. Clinical significance of weight trends during pregnancy. Br Med J 1957 Feb 2; 1(5013): 243–7PubMedCrossRef
195.
Institute of Medicine. Nutrition during pregnancy. Washington, DC: National Academies Press, 1990
196.
Cedergren M. Effects of gestational weight gain and body mass index on obstetric outcome in Sweden. Int J Gynaecol Obstet 2006 Jun; 93(3): 269–74PubMedCrossRef
197.
Nohr EA, Bech BH, Vaeth M, et al. Obesity, gestational weight gain and preterm birth: a study within the Danish National Birth Cohort. Paediatr Perinat Epidemiol 2007 Jan; 21(1): 5–14PubMedCrossRef
198.
Schubring C, Englaro P, Siebler T, et al. Longitudinal analysis of maternal serum leptin levels during pregnancy, at birth and up to six weeks after birth: relation to body mass index, skinfolds, sex steroids and umbilical cord blood leptin levels. Hormone Res 1998; 50(5): 276–83PubMedCrossRef
199.
Okereke NC, Huston-Presley L, Amini SB, et al. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 2004 Sep; 287(3): E472–9PubMedCrossRef
200.
Lederman SA. Pregnancy. In: Hyeymsfield SB, Lohman TG, Wang Z, et al., editors. Human body composition. 2nd ed. Champaign (IL): Human Kinetics, 2005: 299–312
201.
Lederman SA, Pierson Jr RN, Wang J, et al. Body composition measurements during pregnancy. Basic Life Sci 1993; 60: 193–5PubMed
202.
van Raaij JM, Peek ME, Vermaat-Miedema SH, et al. New equations for estimating body fat mass in pregnancy from body density or total body water. Am J Clin Nutr 1988 Jul; 48(1): 24–9PubMed
203.
Duffus GM, MacGillivray I, Dennis KJ. The relationship between baby weight and changes in maternal weight, total body water, plasma volume, electrolytes and proteins and urinary estriol excretion. J Obstet Gynecol Br Commonw 1971; 78: 97–104CrossRef
204.
Stachenfeld NS, Taylor HS. Progesterone increases plasma volume independent of estradiol. J Appl Physiol 2005 Jun; 98(6): 1991–7PubMedCrossRef
205.
Simmons LA, Gillin AG, Jeremy RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 2002 Oct; 283(4): H1627–33PubMed
206.
Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992 Dec; 68(6): 540–3PubMedCrossRef
207.
Ueland K, Novy MJ, Peterson EN, et al. Maternal cardiovascular dynamics. IV: the influence of gestational age on the maternal cardiovascular response to posture and exercise. Am J Obstet Gynecol 1969 Jul 15; 104(6): 856–64PubMed
208.
Brown MA, Gallery ED. Volume homeostasis in normal pregnancy and pre-eclampsia: physiology and clinical implications. Bailliere’s Clin Obstet Gynaecol 1994 Jun; 8(2): 287–310CrossRef
209.
Lee W. Cardiorespiratory alterations during normal pregnancy. Crit Care Clin 1991 Oct; 7(4): 763–75PubMed
210.
Katz R, Karliner JS, Resnik R. Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978 Sep; 58(3 Pt 1): 434–41PubMedCrossRef
211.
Mabie WC, DiSessa TG, Crocker LG, et al. A longitudinal study of cardiac output in normal human pregnancy. Am J Obstet Gynecol 1994 Mar; 170(3): 849–56PubMedCrossRef
212.
Desai DK, Moodley J, Naidoo DP. Echocardiographic assessment of cardiovascular hemodynamics in normal pregnancy. Obstet Gynecol 2004 Jul; 104(1): 20–9PubMedCrossRef
213.
van Oppen AC, van der Tweel I, Alsbach GP, et al. A longitudinal study of maternal hemodynamics during normal pregnancy. Obstet Gynecol 1996 Jul; 88(1): 40–6PubMedCrossRef
214.
Lees MM, Scott DB, Kerr MG, et al. The circulatory effects of recumbent postural change in late pregnancy. Clin Sci 1967 Jun; 32(3): 453–65PubMed
215.
Kinsella SM, Lee A, Spencer JA. Maternal and fetal effects of the supine and pelvic tilt positions in late pregnancy. Eur J Obstet Gynecol Reprod Biol 1990 Jul–Aug; 36(1–2): 11–7PubMedCrossRef
216.
Fujitani S, Baldisseri MR. Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med 2005 Oct; 33 (10 Suppl.): S354–61PubMedCrossRef
217.
Faupel-Badger JM, Hsieh CC, Troisi R, et al. Plasma volume expansion in pregnancy: implications for biomarkers in population studies. Cancer Epidemiol Biomarkers Prev 2007 Sep; 16(9): 1720–3PubMedCrossRef
218.
Metcalfe J, Ueland K. Maternal cardiovascular adjustments to pregnancy. Prog Cardiovasc Dis 1974 Jan–Feb; 16(4): 363–74PubMedCrossRef
219.
Chesley LC. Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol 1972 Feb 1; 112(3): 440–50PubMed
220.
Jepson JH. Endocrine control of maternal and fetal erythropoiesis. Can Med Assoc J 1968 May 4; 98(18): 844–7PubMed
221.
Ervasti M, Kotisaari S, Heinonen S, et al. Elevated serum erythropoietin concentration is associated with coordinated changes in red blood cell and reticulocyte indices of pregnant women at term. Scand J Clin Lab Invest 2008; 68(2): 160–5PubMedCrossRef
222.
Jepson JH, Lowenstein L. Inhibition of the stem-cell action of erythropoietin by estradiol. Proc Soc Exp Biol Med 1966 Nov; 123(2): 457–60PubMedCrossRef
223.
Jepson JH, Lowenstein L. Role of erythropoietin and placental lactogen in the control of erythropoiesis during pregnancy. Can J Physiol Pharmacol 1968 Jul; 46(4): 573–6PubMedCrossRef
224.
Jepson JH, McGarry EE, Lowenstein L. Erythropoietin excretion in a hypopituitary patient: effects of testosterone and vasopressin. Arch Int Med 1968 Sep; 122(3): 265–70CrossRef
225.
Mukundan H, Resta TC, Kanagy NL. 17-Beta estradiol independently regulates erythropoietin synthesis and NOS activity during hypoxia. J Cardiovasc Pharmacol 2004 Feb; 43(2): 312–7PubMedCrossRef
226.
Otto SJ, van Houwelingen AC, Badart-Smook A, et al. Changes in the maternal essential fatty acid profile during early pregnancy and the relation of the profile to diet. Am J Clin Nutr 2001 Feb; 73(2): 302–7PubMed
227.
Ulmsten U, Sundstrom G. Esophageal manometry in pregnant and non-pregnant women. Am J Obstet Gynecol 1978 Oct 1; 132(3): 260–4PubMed
228.
Van Thiel DH, Gavaler JS, Joshi SN, et al. Heartburn of pregnancy. Gastroenterology 1977 Apr; 72(4 Pt 1): 666–8PubMed
229.
O’Sullivan GM, Bullingham RE. The assessment of gastric acidity and antacid effect in pregnant women by a non-invasive radiotelemetry technique. Br J Obstet Gynaecol 1984 Oct; 91(10): 973–8PubMedCrossRef
230.
Dawes M, Chowienczyk PJ. Drugs in pregnancy. Pharmacokinetics in pregnancy. Best Pract Res 2001 Dec; 15(6): 819–26CrossRef
231.
Wong CA, Loffredi M, Ganchiff JN, et al. Gastric emptying of water in term pregnancy. Anesthesiology 2002 Jun; 96(6): 1395–400PubMedCrossRef
232.
Chiloiro M, Darconza G, Piccioli E, et al. Gastric emptying and orocecal transit time in pregnancy. J Gastroenterol 2001 Aug; 36(8): 538–43PubMedCrossRef
233.
Macfie AG, Magides AD, Richmond MN, et al. Gastric emptying in pregnancy. Br J Anaesth 1991 Jul; 67(1): 54–7PubMedCrossRef
234.
Whitehead EM, Smith M, Dean Y, et al. An evaluation of gastric emptying times in pregnancy and the puerperium. Anaesthesia 1993 Jan; 48(1): 53–7PubMedCrossRef
235.
Braverman DZ, Johnson ML, Kern Jr F. Effects of pregnancy and contraceptive steroids on gallbladder function. N Engl J Med 1980 Feb 14; 302(7): 362–4PubMedCrossRef
236.
Van Bodegraven AA, Bohmer CJ, Manoliu RA, et al. Gallbladder contents and fasting gallbladder volumes during and after pregnancy. Scand J Gastroenterol 1998 Sep; 33(9): 993–7PubMedCrossRef
237.
Kapicioglu S, Gurbuz S, Danalioglu A, et al. Measurement of gallbladder volume with ultrasonography in pregnant women. Can J Gastroenterol 2000 May; 14(5): 403–5PubMed
238.
Hahm JS, Park JY, Song SC, et al. Gallbladder motility change in late pregnancy and after delivery. Korean J Intern Med 1997 Jan; 12(1): 16–20PubMed
239.
Bacq Y, Zarka O, Brechot JF, et al. Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996 May; 23(5): 1030–4PubMedCrossRef
240.
Jamjute P, Ahmad A, Ghosh T, et al. Liver function test and pregnancy. J Matern Fetal Neonatal Med 2009 Mar; 22(3): 274–83PubMedCrossRef
241.
Knox TA. Evaluation of abnormal liver function in pregnancy. Semin Perinatol 1998 Apr; 22(2): 98–103PubMedCrossRef
242.
Tindall VR. The liver in pregnancy. Clin Obstet Gynaecol 1975; 2(2): 441–62
243.
Munnell EW, Taylor HC. Liver blood flow in pregnancy-hepatic vein catheterization. J Clin Invest 1947 Sep; 26(5): 952–6PubMedCrossRef
244.
Clapp JF, Stepanchak W, Tomaselli J, et al. Portal vein blood flow-effects of pregnancy, gravity, and exercise. Am J Obstet Gynecol 2000 Jul; 183(1): 167–72PubMed
245.
Roobottom CA, Hunter JD, Weston MJ, et al. Hepatic venous Doppler waveforms: changes in pregnancy. J Clin Ultrasound 1995 Oct; 23(8): 477–82PubMedCrossRef
246.
Gyselaers W, Molenberghs G, Mesens T, et al. Maternal hepatic vein Doppler velocimetry during uncomplicated pregnancy and pre-eclampsia. Ultrasound Med Biol 2009 Aug; 35(8): 1278–83PubMedCrossRef
247.
Lui EY, Steinman AH, Cobbold RS, et al. Human factors as a source of error in peak Doppler velocity measurement. J Vasc Surg 2005 Nov; 42(5): 972–9PubMedCrossRef
248.
Yzet T, Bouzerar R, Allart JD, et al. Hepatic vascular flow measurements by phase contrast MRI and doppler echography: a comparative and reproducibility study. J Magn Reson Imaging 2010 Mar; 31(3): 579–88PubMedCrossRef
249.
Mesens T, Tomsin K, Molenberghs G, et al. Reproducibility and repeatability of maternal venous Doppler flow measurements in renal interlobar and hepatic veins. Ultrasound Obstet Gynecol 2010 Jul; 36(1): 120–1PubMedCrossRef
250.
Hogstedt S, Lindberg B, Rane A. Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol 1983; 24(2): 217–20PubMedCrossRef
251.
Hogstedt S, Rane A. Plasma concentration-effect relationship of metoprolol during and after pregnancy. Eur J Clin Pharmacol 1993; 44(3): 243–6PubMedCrossRef
252.
Sandstrom B, Lindeberg S, Lundborg P, et al. Disposition of the adrenergic blocker metoprolol in the late pregnant women, the amniotic fluid, the cord blood and the neonate. Clin Exp Hypertension 1983; 2(1): 75–82
253.
Wadelius M, Darj E, Frenne G, et al. Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther 1997 Oct; 62(4): 400–7PubMedCrossRef
254.
Abduljalil K, Frank D, Gaedigk A, et al. Assessment of activity levels for CYP2D6*1, CYP2D6*2, and CYP2D6*41 genes by population pharmaco-kinetics of dextromethorphan. Clin Pharmacol Ther 2010 Nov; 88(5): 643–51PubMedCrossRef
255.
Jeong H, Choi S, Song JW, et al. Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica 2008 Jan; 38(1): 62–75PubMedCrossRef
256.
Urquhart BL, Tirona RG, Kim RB. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for inter-individual variability in response to drugs. J Clin Pharmacol 2007 May; 47(5): 566–78PubMedCrossRef
257.
Aldridge A, Bailey J, Neims AH. The disposition of caffeine during and after pregnancy. Semin Perinatol 1981 Oct; 5(4): 310–4PubMed
258.
Brazier JL, Ritter J, Berland M, et al. Pharmacokinetics of caffeine during and after pregnancy. Dev Pharmacol Ther 1983; 6(5): 315–22PubMed
259.
Knutti R, Rothweiler H, Schlatter C. Effect of pregnancy on the pharmacokinetics of caffeine. Eur J Clin Pharmacol 1981; 21(2): 121–6PubMedCrossRef
260.
Gardner MJ, Schatz M, Cousins L, et al. Longitudinal effects of pregnancy on the pharmacokinetics of theophylline. Eur J Clin Pharmacol 1987; 32(3): 289–95PubMedCrossRef
261.
Dempsey D, Jacob 3rd P, Benowitz NL. Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther 2002 May; 301(2): 594–8PubMedCrossRef
262.
Lander CM, Smith MT, Chalk JB, et al. Bioavailability and pharmacokinetics of phenytoin during pregnancy. Eur J Clin Pharmacol 1984; 27(1): 105–10PubMed
263.
Dickinson RG, Hooper WD, Wood B, et al. The effect of pregnancy in humans on the pharmacokinetics of stable isotope labelled phenytoin. Br J Clin Pharmacol 1989 Jul; 28(1): 17–27PubMedCrossRef
264.
Hebert MF, Ma X, Naraharisetti SB, et al. Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 2009 Jun; 85(6): 607–14PubMedCrossRef
265.
McGready R, Stepniewska K, Seaton E, et al. Pregnancy and use of oral contraceptives reduces the biotransformation of proguanil to cycloguanil. Eur J Clin Pharmacol 2003 Oct; 59(7): 553–7PubMedCrossRef
266.
Wangboonskul J, White NJ, Nosten F, et al. Single dose pharmacokinetics of proguanil and its metabolites in pregnancy. Eur J Clin Pharmacol 1993; 44(3): 247–51PubMedCrossRef
267.
Heikkinen T, Ekblad U, Palo P, et al. Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003 Apr; 73(4): 330–7PubMedCrossRef
268.
Heikkinen T, Ekblad U, Kero P, et al. Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002 Aug; 72(2): 184–91PubMedCrossRef
269.
Buchanan ML, Easterling TR, Carr DB, et al. Clonidine pharmacokinetics in pregnancy. Drug Metab Dispos 2009 Apr; 37(4): 702–5PubMedCrossRef
270.
Kanto J, Sjovall S, Erkkola R, et al. Placental transfer and maternal midazolam kinetics. Clin Pharmacol Ther 1983 Jun; 33(6): 786–91PubMedCrossRef
271.
Prevost RR, Akl SA, Whybrew WD, et al. Oral nifedipine pharmacokinetics in pregnancy-induced hypertension. Pharmacotherapy 1992; 12(3): 174–7PubMed
272.
Jarvis MA, Wu-Pong S, Kniseley JS, et al. Alterations in methadone metabolism during late pregnancy. J Addict Dis 1999; 18(4): 51–61PubMedCrossRef
273.
Wolff K, Boys A, Rostami-Hodjegan A, et al. Changes to methadone clearance during pregnancy. Eur J Clin Pharmacol 2005 Nov; 61(10): 763–8PubMedCrossRef
274.
Hardman J, Endres L, Fischer P, et al. Pharmacokinetics of labetalol in pregnancy. Pharmacotherapy 2005; 25(10): 1493
275.
Fotopoulou C, Kretz R, Bauer S, et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period. Epilepsy Res 2009 Jul; 85(1): 60–4PubMedCrossRef
276.
Franco V, Mazzucchelli I, Gatti G, et al. Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. Ther Drug Monit 2008 Aug; 30(4): 544–7PubMed
277.
Tran TA, Leppik IE, Blesi K, et al. Lamotrigine clearance during pregnancy. Neurology 2002 Jul 23; 59(2): 251–5PubMedCrossRef
278.
Rostami-Hodjegan A, Kroemer HK, Tucker GT. In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity. Pharmacogenetics 1999 Jun; 9(3): 277–86PubMedCrossRef
279.
Johnson TN, Tucker GT, Rostami-Hodjegan A. Development of CYP2D6 and CYP3A4 in the first year of life. Clin Pharmacol Ther 2008 May; 83(5): 670–1PubMedCrossRef
280.
Anderson GD, Carr DB. Effect of pregnancy on the pharmacokinetics of antihypertensive drugs. Clin Pharmacokinet 2009; 48(3): 159–68PubMedCrossRef
281.
Anderson GD. Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation. Expert Opin Drug Metab Toxicol 2006 Dec; 2(6): 947–60PubMedCrossRef
282.
Lind AB, Wadelius M, Darj E, et al. Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy. Pharmacol Toxicol 2003 Jun; 92(6): 295–9PubMedCrossRef
283.
Christensen T, Klebe JG, Bertelsen V, et al. Changes in renal volume during normal pregnancy. Acta Obstet Gynecol Scand 1989; 68(6): 541–3PubMed
284.
Bailey RR, Rolleston GL. Kidney length and ureteric dilatation in the puerperium. J Obstet Gynaecol Br Commonw 1971 Jan; 78(1): 55–61PubMedCrossRef
285.
Davison JM. The effect of pregnancy on kidney function in renal allograft recipients. Kidney Int 1985 Jan; 27(1): 74–9PubMedCrossRef
286.
Conrad KP. Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia. Semin Nephrol 2011 Jan; 31(1): 15–32PubMedCrossRef
287.
Fried AM, Woodring JH, Thompson DJ. Hydronephrosis of pregnancy: a prospective sequential study of the course of dilatation. J Ultrasound Med 1983 Jun; 2(6): 255–9PubMed
288.
Grenier N, Pariente JL, Trillaud H, et al. Dilatation of the collecting system during pregnancy: physiologic vs obstructive dilatation. Eur Radiol 2000; 10(2): 271–9PubMedCrossRef
289.
Hebert MF, Carr DB, Anderson GD, et al. Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol 2005 Jan; 45(1): 25–33PubMedCrossRef
290.
Oatridge A, Holdcroft A, Saeed N, et al. Change in brain size during and after pregnancy: study in healthy women and women with preeclampsia. Am J Neuroradiol 2002 Jan; 23(1): 19–26PubMed
291.
McCall M. Cerebral blood flow and metabolism in toxemias of pregnancy. Surg Gynecol Obstet 1949 Dec; 89(6): 715–21, illustPubMed
292.
Benacerraf BR, Shipp TD, Lyons JG, et al. Width of the normal uterine cavity in premenopausal women and effect of parity. Obstet Gynecol 2010 Aug; 116(2 Pt 1): 305–10PubMedCrossRef
293.
ICPR. International Commission on Radiological Protection. Report of the Task Group on Reference Man. Oxford: Pergammon Press, 1975. ICRP publication no. 23
294.
Milligan D, Drife JO, Short RV. Changes in breast volume during normal menstrual cycle and after oral contraceptives. Br Med J 1975 Nov 29; 4(5995): 494–6PubMedCrossRef
295.
Hegenbart L, Na YH, Zhang JY, et al. A Monte Carlo study of lung counting efficiency for female workers of different breast sizes using deformable phantoms. Phys Med Biol 2008 Oct 7; 53(19): 5527–38PubMedCrossRef
296.
Loughry CW, Sheffer DB, Price TE, et al. Breast volume measurement of 598 women using biostereometric analysis. Ann Plast Surg 1989 May; 22(5): 380–5PubMedCrossRef
297.
Malini S, Smith EO, Goldzieher JW. Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use. Obstet Gynecol 1985 Oct; 66(4): 538–41PubMed
298.
Pickles VR. Blood-flow estimations as indices of mammary activity. J Obstet Gynaecol Br Emp 1953 Jun; 60(3): 301–11PubMedCrossRef
299.
Burd LI, Dorin M, Philipose V, et al. The relationship of mammary temperature to parturition in human subjects. Am J Obstet Gynecol 1977 Jun 1; 128(3): 272–8PubMed
300.
Sambrook M, Bamber JC, Minasian H, et al. Ultrasonic Doppler study of the hormonal response of blood flow in the normal human breast. Ultrasound Med Biol 1987 Mar; 13(3): 121–9PubMedCrossRef
301.
Jensen D, Webb KA, O’Donnell DE. Chemical and mechanical adaptations of the respiratory system at rest and during exercise in human pregnancy. Appl Physiol Nutr Metab 2007 Dec; 32(6): 1239–50PubMedCrossRef
302.
Hegewald MJ, Crapo RO. Respiratory physiology in pregnancy. Clin Chest Med 2011 Mar; 32(1): 1–13PubMedCrossRef
303.
Elkus R, Popovich Jr J. Respiratory physiology in pregnancy. Clin Chest Med 1992 Dec; 13(4): 555–65PubMed
304.
Contreras G, Gutierrez M, Beroiza T, et al. Ventilatory drive and respiratory muscle function in pregnancy. Am Rev Respir Dis 1991 Oct; 144(4): 837–41PubMedCrossRef
305.
McAuliffe F, Kametas N, Costello J, et al. Respiratory function in singleton and twin pregnancy. BJOG 2002 Jul; 109(7): 765–9PubMedCrossRef
306.
Gardner MO, Doyle NM. Asthma in pregnancy. Obstet Gynecol Clin North Am 2004 Jun; 31(2): 385–413, viiPubMedCrossRef
307.
Spatling L, Fallenstein F, Huch A, et al. The variability of cardiopulmonary adaptation to pregnancy at rest and during exercise. Br J Obstet Gynaecol 1992 Jul; 99 Suppl. 8: 1–40PubMed
308.
Rees GB, Broughton Pipkin F, Symonds EM, et al. A longitudinal study of respiratory changes in normal human pregnancy with cross-sectional data on subjects with pregnancy-induced hypertension. Am J Obstet Gynecol 1990 Mar; 162(3): 826–30PubMedCrossRef
309.
Knuttgen HG, Emerson Jr K. Physiological response to pregnancy at rest and during exercise. J Appl Physiol 1974 May; 36(5): 549–53PubMed
310.
Pernoll ML, Metcalfe J, Kovach PA, et al. Ventilation during rest and exercise in pregnancy and postpartum. Respir Physiol 1975 Dec; 25(3): 295–310PubMedCrossRef
311.
Pernoll ML, Metcalfe J, Schlenker TL, et al. Oxygen consumption at rest and during exercise in pregnancy. Respir Physiol 1975 Dec; 25(3): 285–93PubMedCrossRef
312.
Emerson Jr K, Saxena BN, Poindexter EL. Caloric cost of normal pregnancy. Obstet Gynecol 1972 Dec; 40(6): 786–94PubMed
313.
De Swiet M. The respiratory system. 2nd ed. Oxford: Blackwell Science Ltd, 1991
314.
Bronstein MN, Mak RP, King JC. Unexpected relationship between fat mass and basal metabolic rate in pregnant women. Br J Nutr 1996 May; 75(5): 659–68PubMedCrossRef
315.
Liu JH. Endocrinology of pregnancy. In: Creasy RK, Resnik R, Iams JD, editors. Maternal-fetal medicine: principles and practice. 5th ed. Philadelphia (PA): Saunders, 2004: 121–34
316.
Holmdahl TH, Johansson ED, Wide L. The site of progesterone production in early pregnancy. Acta Endocrinol 1971 Jun; 67(2): 353–61PubMed
317.
Bernstein L, Lipworth L, Ross RK, et al. Correlation of estrogen levels between successive pregnancies. Am J Epidemiol 1995 Sep 15; 142(6): 625–8PubMed
318.
Blackburn ST. Fetal, and neonatal physiology: a clinical perspective. 3rd ed. St Louis (MO): Saunders, 2007
319.
Hytten F, Chamberlain G. Clinical physiology in obstetrics. 2nd ed. Oxford: Blackwell Scientific, 1980
320.
Berghout A, Endert E, Ross A, et al. Thyroid function and thyroid size in normal pregnant women living in an iodine replete area. Clin Endocrinol 1994 Sep; 41(3): 375–9CrossRef
321.
Fister P, Gaberscek S, Zaletel K, et al. Thyroid volume changes during pregnancy and after delivery in an iodine-sufficient Republic of Slovenia. Eur J Obstet Gynecol Reproduct Biol 2009 Jul; 145(1): 45–8CrossRef
322.
Vila L, Legaz G, Barrionuevo C, et al. Iodine status and thyroid volume changes during pregnancy: results of a survey in Aran Valley (Catalan Pyrenees). J Endocrinol Invest 2008 Oct; 31(10): 851–5PubMed
323.
Antonangeli L, Maccherini D, Cavaliere R, et al. Comparison of two different doses of iodide in the prevention of gestational goiter in marginal iodine deficiency: a longitudinal study. Eur J Endocrinol 2002 Jul; 147(1): 29–34PubMedCrossRef
324.
Kumari R, Jaisankar TJ, Thappa DM. A clinical study of skin changes in pregnancy. Indian J Dermatol Venereol Leprol 2007 Mar–Apr; 73(2): 141PubMed
325.
Muallem MM, Rubeiz NG. Physiological and biological skin changes in pregnancy. Clinics Dermatol 2006 Mar–Apr; 24(2): 80–3CrossRef
326.
Wade TR, Wade SL, Jones HE. Skin changes and diseases associated with pregnancy. Obstet Gynecol 1978 Aug; 52(2): 233–42PubMed
327.
Ginsburg J, Duncan SL. Peripheral blood flow in normal pregnancy. Cardiovascular Res 1967 Apr; 1(2): 132–7CrossRef
328.
Beinder E, Huch A, Huch R. Peripheral skin temperature and micro-circulatory reactivity during pregnancy: a study with thermography. J Perinatal Med 1990; 18(5): 383–90CrossRef
329.
Ashton H. Cigarette smoking in pregnancy: differences in peripheral circulation between smokers and non-smokers. Br J Obstet Gynaecol 1975 Nov; 82(11): 868–81PubMedCrossRef
330.
Katz M, Sokal MM. Skin perfusion in pregnancy. Am J Obstet Gynecol 1980 May 1; 137(1): 30–3PubMed
331.
de Mul FF, Blaauw J, Aarnoudse JG, et al. Diffusion model for iontophoresis measured by laser-Doppler perfusion flowmetry, applied to normal and preeclamptic pregnancies. J Biomed Optics 2007 Jan–Feb; 12(1): 014032CrossRef
332.
Pitkin RM. Nutritional support in obstetrics and gynecology. Clin Obstet Gynecol 1976 Sep; 19(3): 489–513PubMedCrossRef
333.
Rodeck CH, Whittle MJ. Fetal medicine: basic science and clinical practice. 2nd ed. Oxford: Churchill Livingstone, 2008
334.
335.
Levine D. Three-dimensional fetal MR imaging: will it fulfill its promise? Radiology 2001 May; 219(2): 313–5PubMed
336.
Luecke RH, Wosilait WD, Young JF. Mathematical modeling of human embryonic and fetal growth rates. Growth Dev Aging 1999 Spring-Summer; 63(1–2): 49–59PubMed
337.
Wosilait WD, Luecke RH, Young JF. A mathematical analysis of human embryonic and fetal growth data. Growth Dev Aging 1992 Winter; 56(4): 249–57PubMed
338.
Wilcox MA, Johnson IR, Maynard PV, et al. The individualised birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol 1993 Apr; 100(4): 342–7PubMedCrossRef
339.
Blair EM, Liu Y, de Klerk NH, et al. Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database. BMC Pediatrics 2005; 5(1): 13PubMedCrossRef
340.
Bertino E, Di Battista E, Bossi A, et al. Fetal growth velocity: kinetic, clinical, and biological aspects. Arch Dis Child 1996 Jan; 74(1): F10–5CrossRef
341.
Enders AC, Blankenship TN. Comparative placental structure. Adv Drug Deliv Rev 1999 Jun 14; 38(1): 3–15PubMedCrossRef
342.
Jones CJ, Fox H. Ultrastructure of the normal human placenta. Electron Microsc Rev 1991; 4(1): 129–78PubMedCrossRef
343.
Stoz F, Schuhmann RA, Schebesta B. The development of the placental villus during normal pregnancy: morphometric data base. Arch Gynecol Obstet 1988; 244(1): 23–32PubMedCrossRef
344.
Pollex EK, Hutson JR. Genetic polymorphisms in placental transporters: implications for fetal drug exposure to oral antidiabetic agents. Expert Opin Drug Metab Toxicol 2011 Mar; 7(3): 325–39PubMedCrossRef
345.
Prouillac C, Lecoeur S. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies. Drug Metab Dispos 2010 Oct; 38(10): 1623–35PubMedCrossRef
346.
Zharikova OL, Fokina VM, Nanovskaya TN, et al. Identification of the major human hepatic and placental enzymes responsible for the biotransformation of glyburide. Biochem Pharmacol 2009 Dec 15; 78(12): 1483–90PubMedCrossRef
347.
Ceckova-Novotna M, Pavek P, Staud F. P-glycoprotein in the placenta: expression, localization, regulation and function. Reproduct Toxicol 2006 Oct; 22(3): 400–10CrossRef
348.
Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004; 43(8): 487–514PubMedCrossRef
349.
Hakkola J, Pelkonen O, Pasanen M, et al. Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity. Crit Rev Toxicol 1998 Jan; 28(1): 35–72PubMedCrossRef
350.
Kuhlmann RS, Warsof S. Ultrasound of the placenta. Clin Obstet Gynecol 1996 Sep; 39(3): 519–34PubMedCrossRef
351.
Younoszai MK, Haworth JC. Chemical composition of the placenta in normal preterm, term, and intrauterine growth-retarded infants. Am J Obstet Gynecol 1969 Jan 15; 103(2): 262–4PubMed
352.
Younoszai MK, Haworth JC. Placental dimensions and relations in preterm, term, and growth-retarded infants. Am J Obstet Gynecol 1969 Jan 15; 103(2): 265–71PubMed
353.
Garrow JS. The relationship of foetal growth to size and composition of the placenta. Proc Royal Soc Med 1970 May; 63(5): 498–500
354.
Leary SD, Godfrey KM, Greenaway LJ, et al. Contribution of the umbilical cord and membranes to untrimmed placental weight. Placenta 2003 Feb–Mar; 24(2–3): 276–8PubMedCrossRef
355.
Yao AC, Moinian M, Lind J. Distribution of blood between infant and placenta after birth. Lancet 1969 Oct 25; 2(7626): 871–3PubMedCrossRef
356.
Brace RA. Progress toward understanding the regulation of amniotic fluid volume: water and solute fluxes in and through the fetal membranes. Placenta 1995 Jan; 16(1): 1–18PubMedCrossRef
357.
Wagner G, Fuchs F. The volume of amniotic fluid in the first half of human pregnancy. J Obstet Gynaecol Br Empire 1962 Feb; 69: 131–6CrossRef
358.
Touboul C, Boulvain M, Picone O, et al. Normal fetal urine production rate estimated with 3-dimensional ultrasonography using the rotational technique (virtual organ computer-aided analysis). Am J Obstet Gynecol 2008 Jul; 199(1): 57e1–5CrossRef
359.
Garby L. Studies on transfer of matter across membranes with special reference to the isolated human amniotic membrane and the exchange of amniotic fluid. Acta Physiol Scand 1957; 40(137): 1–84
360.
Dildy GA, Lira N, Moise Jr KJ, et al. Amniotic fluid volume assessment: comparison of ultrasonographic estimates versus direct measurements with a dye-dilution technique in human pregnancy. Am J Obstet Gynecol 1992 Oct; 167(4 Pt 1): 986–94PubMedCrossRef
361.
Gramellini D, Fieni S, Verrotti C, et al. Ultrasound evaluation of amniotic fluid volume: methods and clinical accuracy. Acta Biomed 2004; 75 Suppl. 1: 40–4PubMed
362.
Lukaski HC. Methods for the assessment of human body composition: traditional and new. Am J Clin Nutr 1987 Oct; 46(4): 537–56PubMed
363.
Siri WE. Gross composition of the body. In: Tobias CA, Lawrence JH, editors. Advances in biological and medical physics. New York: Academic, 1956: 239–80
364.
Hopkinson JM, Butte NF, Ellis KJ, et al. Body fat estimation in late pregnancy and early postpartum: comparison of two-, three-, and four-component models. Am J Clin Nutr 1997 Feb; 65(2): 432–8PubMed
Metadaten
Titel
Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy
A Database for Parameters Required in Physiologically Based Pharmacokinetic Modelling
verfasst von
Dr Khaled Abduljalil
Penny Furness
Trevor N. Johnson
Amin Rostami-Hodjegan
Hora Soltani
Publikationsdatum
01.06.2012
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 6/2012
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.2165/11597440-000000000-00000

Weitere Artikel der Ausgabe 6/2012

Clinical Pharmacokinetics 6/2012 Zur Ausgabe

Original Research Article

Vinflunine Oral Pharmacokinetics and Absolute Bioavailability of Soft and Hard Gelatin Capsules

Original Research Article

Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Stable Coronary Artery Disease

Review Article

Clinical Pharmacokinetics and Therapeutic Efficacy of Esmolol

Review Article

Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody